Bristol-Myers Squibb Co., of New York, named Francis Cuss executive vice president and chief scientific officer, effective July 1...EntreMed Inc., of Rockville, Md., appointed Ken K. Ren CEO, and added James Huang and Y. Alexander Wu to its board

F2G Ltd., of Manchester, UK, appointed Ian Nicholson CEO and board member...NeuroVive Pharmaceutical AB, of Lund, Sweden, elected Anna Malm Bernsten and Boel Flodgren to its board...Vermillion Inc., of Austin, Texas, appointed Thomas McLain president and CEO

Champions Oncology Inc., of Hackensack, N.J., added Dan Mendelson and Arthur G...Cytori Therapeutics Inc., of San Diego, named Steven Kesten executive vice president and chief medical officer...OncoSec Medical Inc., of San Diego, appointed Sanjiv S. Agarwala, Axel Hauschild, Kim A. Margolin and Vernon K. Sondak to its new melanoma advisory board (MAB) and named Adil I. Daud chairman of the MAB

Ambrx Inc., of San Diego, named Lawson Macartney president and CEO...Esperion Therapeutics Inc., of Plymouth, Mich., named Tim Mayleben president and CEO and Roger Newton executive chairman and chief scientific officer...plc, of Dublin, Ireland, added Richard T. Colllier and Shane Cooke to its board

CytRx Corp., of Los Angeles, named Daniel Levitt executive vice president, and he continues as chief medical officer...OvaScience Inc., of Cambridge, Mass., named Alison Lawton chief operating officer and Christopher Beck chief commercial officer...Relypsa Inc., of Redwood City, Calif., added Paul J. Hastings and David W.J. McGirr to its board

Summit plc, of Oxford, UK, added Jim Mellon and Frank Armstrong to its board...and Justin Smith senior vice president, general manager, U.S. Rx dermatology...Verastem Inc., of Cambridge, Mass., added Alison Lawton and Michael Kauffman to its board

Alimera Sciences Inc., of Atlanta, appointed Philip Ashman senior vice president and European managing director and named Eric Teo vice president and European medical director...Anne-Marie Swift will serve as vice president and European marketing director...Ohr Pharmaceuticals Inc., of New York, added Jeffrey S. Heier and Daniel Roth to its scientific advisory board

Blueprint Medicines, of Cambridge, Mass., appointed Chris Varma president and CEO, and named Daniel S. Lynch executive chairman of its board...HemoShear LLC, of Charlottesville, Va., added Mehmood Khan and Frederick W.K. Brown to its board

Fedora Pharmaceuticals Inc., of Edmonton, Alberta, appointed Ronald W. Odynski and Leonard E. Post to its newly created board, and named Christopher Micetich board chairman...Pharmanest AB, of Stockholm, Sweden, added Per Lango and Gunilla Ekstrom to its board, and named Alan Raffensperger board chairman

Cerecor Inc., of Baltimore, appointed James Vornov senior vice president, clinical development and regulatory affairs, and John Kaiser vice president of commercialization and business development...Fate Therapeutics Inc., of San Diego, appointed Christian Weyer president and CEO

Althea Technologies Inc., of San Diego, named Rick Hancock president and CEO, Chris Duffy senior vice president of operations and E.J. Brandreth senior vice president of quality and regulatory...SpringLeaf Therapeutics Inc., of Boston, appointed Pieter Muntendam president and CEO

Imprimis Pharmaceuticals Inc., of Solana Beach, Calif., added Lee S. Simon and Allan Green to its science and regulatory advisory board...Islet Sciences Inc., of New York, added Kevan Herold and Morton Printz to its scientific advisory board

Actinium Pharmaceuticals Inc., of New York, hired Jack V. Talley as president and CEO and added Enza Guagenti as chief financial officer...BioMotiv LLC, of Cleveland, named Baiju R. Shah CEO and board member, effective Sept...ImmunoCellular Therapeutics Ltd., of Los Angeles, named John S. Yu interim CEO and president

he will chair the audit committee and serve on the compensation committee...Dynavax Technologies Corp., of Berkeley, Calif., named Christine Larson vice president and chief financial officer...Nile Therapeutics Inc., of San Mateo, Calif., named Darlene Horton president and CEO, and director

Caisson Biotech LLC, of Austin, Texas, appointed Glenn Nedwin CEO and president...Quanterix Corp., of Lexington, Mass., named Paul Chapman president and CEO...RXi Pharmaceuticals Corp., of Westborough, Mass., added Jeannette Graf and Leroy Young to its scientific advisory board

Akshay Vaishnaw executive vice president and chief medical officer...and Thomas Rollins senior vice president of program and portfolio management

A.P. Pharma Inc., of Redwood City, Calif., added Barry Quart and Stephen Davis to it board...Saladax Biomedical Inc., of Bethlehem, Pa., named Kevin Harter president and CEO...Sequenom Inc., of San Diego, named Carolyn Beaver vice president and chief accounting officer

Generex Biotechnology Corp., of Worcester, Mass., added Keith Knutson and James Mule to its scientific advisory board...PolyTherics Ltd., of London, added Anker Lundemose and Nigel Pitchford to its board...Promedior Inc., of Malvern, Pa., appointed Suzanne Bruhn president and CEO

Tris Pharma Inc., of Monmouth Junction, N.J., named Amanda Wohlleber vice president of scale-up and technical services and Rajul Parikh vice president, operations...Vaximm AG, of Basel, Switzerland, and Mannheim, Germany, appointed Jean Paul Prieels to its board...Ziopharm Oncology Inc., of New York, appointed Jason Amello executive vice president and chief financial officer